Published in Br Med J (Clin Res Ed) on June 27, 1981
Monocyte and macrophage differentiation: circulation inflammatory monocyte as biomarker for inflammatory diseases. Biomark Res (2014) 1.49
The stimulation of IL-2 production by anti-rheumatic drugs. Immunology (1989) 1.00
Enhanced bacterial phagocytosis by peripheral blood monocytes in rheumatoid arthritis. Ann Rheum Dis (1984) 0.91
Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes. Ann Rheum Dis (1983) 0.85
Macrophages in immunopathology of atherosclerosis: a target for diagnostics and therapy. Curr Pharm Des (2015) 0.79
Monocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and Therapy. J Immunol Res (2016) 0.75
Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl (1968) 60.35
Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol (1971) 20.35
Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease. J Clin Invest (1976) 5.96
The clearance of antigen antibody complexes from the blood by the reticuloendothelial system. J Immunol (1959) 3.25
Circulating immune complexes and complement activation in primary biliary cirrhosis. N Engl J Med (1978) 2.30
Kinetics of phagocytosis and intracellular killing of Candida albicans by human granulocytes and monocytes. Infect Immun (1977) 2.23
A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med (1969) 2.11
Metabolism of the third component of complement (C3) in patients with rheumatoid arthritis. Arthritis Rheum (1972) 1.65
Cryoimmunoglobulinemia in rheumatoid arthritis. Significance in serum of patients with rheumatoid vasculitis. J Clin Invest (1975) 1.62
The development of macrophages from large mononuclear cells in the blood of patients with inflammatory disease. J Clin Invest (1972) 1.60
Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum (1972) 1.56
Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest (1978) 1.45
Size distribution, electronic recognition, and counting of human blood monocytes. Blood (1976) 1.20
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum (1998) 4.37
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage (2007) 4.34
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann Rheum Dis (2007) 2.89
Measurement of joint inflammation. A radioisotopic method. Ann Rheum Dis (1970) 2.35
Total body calcium in rheumatoid arthritis: effects of disease activity and corticosteroid treatment. Br Med J (Clin Res Ed) (1982) 2.24
Experimentally-induced osteoarthritis in the dog. Ann Rheum Dis (1973) 2.12
Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol (1987) 2.12
Tumour necrosis factor in synovial exudates. Ann Rheum Dis (1988) 2.09
Liver disease in Sjögren's syndrome and rheumatoid arthritis. Lancet (1970) 2.00
Non-secretion of ABO blood group antigens as a host susceptibility factor in the spondyloarthropathies. Br Med J (Clin Res Ed) (1987) 1.91
Ibuprofen in the treatment of rheumatoid arthritis and osteo-arthritis. Ann Rheum Dis (1967) 1.89
Bronchodilatation after inhalation of the antihistamine clemastine. Thorax (1978) 1.76
Liver disease in rheumatoid arthritis and Sjøgren's syndrome. Prospective study using biochemical and serological markers of hepatic dysfunction. Ann Rheum Dis (1975) 1.66
Derivation of knee joint synovial perfusion. Using the Xenon (133Xe) clearance technique. Ann Rheum Dis (1970) 1.59
Lymphoedema associated with active inflammatory arthritis in a patient with congenital lymphatic hypoplasia. Br J Rheumatol (1995) 1.55
Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) (1986) 1.49
Health economics as an aspect of health outcome: basic principles and application in rheumatoid arthritis. Br J Rheumatol (1995) 1.43
Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) (1980) 1.41
Immunological responses in Sjogren's syndrome and rheumatoid arthritis. Clin Exp Immunol (1971) 1.41
Rheumatoid lymphadenopathy. Ann Rheum Dis (1968) 1.39
Effect of Glyvenol (CIBA) on pain and on capillary resistance in rheumatoid arthritis. Ann Rheum Dis (1969) 1.39
Measuring health status in British patients with rheumatoid arthritis: reliability, validity and responsiveness of the short form 36-item health survey (SF-36). Br J Rheumatol (1998) 1.38
Abnormalities in mineral metabolism suggestive of parathyroid over-activity in rheumatoid arthritis. Curr Med Res Opin (1975) 1.36
Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation. BMJ (1998) 1.35
Non-steroidal analgesic and anti-inflammatory agents. Br Med J (Clin Res Ed) (1983) 1.35
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis. Ann Rheum Dis (2004) 1.28
Expression of purine overproduction in a series of 8-azaguanine-resistant diploid human lymphoblast lines. Proc Natl Acad Sci U S A (1974) 1.25
Stimulation of human purine synthesis de novo by fructose infusion. Metabolism (1975) 1.25
Dermatitis herpetiformis--a skin manifestation of a generalized disturbance in immunity. Q J Med (1978) 1.24
Signalling cascades in mechanotransduction: cell-matrix interactions and mechanical loading. Scand J Med Sci Sports (2009) 1.20
Mechanotransduction via integrins and interleukin-4 results in altered aggrecan and matrix metalloproteinase 3 gene expression in normal, but not osteoarthritic, human articular chondrocytes. Arthritis Rheum (2000) 1.19
Radioisotope study of small joint inflammation in rheumatoid arthritis. Ann Rheum Dis (1971) 1.15
Bone loss in rheumatoid arthritis and primary generalized osteoarthrosis: effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements. Br J Rheumatol (1986) 1.14
Penetration of sodium fusidate (Fucidin) in the synovial cavity. Scand J Rheumatol (1972) 1.13
Integrin and mechanosensitive ion channel-dependent tyrosine phosphorylation of focal adhesion proteins and beta-catenin in human articular chondrocytes after mechanical stimulation. J Bone Miner Res (2000) 1.13
Isotope studies in normal and diseased knee joints: 99mTc uptake related to clinical assessment and to synovial perfusion measured by the 133Xe clearance technique. Clin Sci (1971) 1.10
Rheological simulation of synovial fluid by a synthetic polymer solution. Nature (1969) 1.09
Integrin-interleukin-4 mechanotransduction pathways in human chondrocytes. Clin Orthop Relat Res (2001) 1.08
Macular lesions during systemic therapy with depot tetracosactrin. Br J Ophthalmol (1970) 1.07
Integrin-regulated secretion of interleukin 4: A novel pathway of mechanotransduction in human articular chondrocytes. J Cell Biol (1999) 1.07
Eating and corticosteroid levels. Br Med J (1969) 1.06
Translocation of protein kinase C to a Triton-insoluble sub-cellular compartment induced by the lipophilic gold compound auranofin. Biochem Pharmacol (1988) 1.06
Hyperpolarisation of cultured human chondrocytes following cyclical pressure-induced strain: evidence of a role for alpha 5 beta 1 integrin as a chondrocyte mechanoreceptor. J Orthop Res (1997) 1.05
Macrovascular disease and systemic sclerosis. Ann Rheum Dis (2000) 1.02
Bone mass in ankylosing spondylitis. J Rheumatol (1986) 1.02
Uptake of chloroquine and hydroxychloroquine by human blood leucocytes in vitro: relation to cellular concentrations during antirheumatic therapy. Ann Rheum Dis (1987) 1.02
Modulation by phorbol myristate acetate of arachidonic acid release and leukotriene synthesis by human polymorphonuclear leukocytes stimulated with A23187. Biochem Biophys Res Commun (1986) 1.00
The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: a consensus report. Osteoporos Int (2004) 1.00
Indices of inflammatory activity. Relationship between isotope studies and clinical methods. Ann Rheum Dis (1970) 0.99
Reversible gynaecomastia associated with D-penicillamine in a man with rheumatoid arthritis. Br Med J (Clin Res Ed) (1982) 0.99
The economics of arthritis. Bull Rheum Dis (1973) 0.98
Zinc increases phorbol ester receptors in intact B-cells, neutrophil polymorphs and platelets. FEBS Lett (1989) 0.98
Bone mass in nodal primary generalised osteoarthrosis. Ann Rheum Dis (1984) 0.97
Otolaryngological aspects of Sjögren's syndrome. Br Med J (1971) 0.97
A study of amyloid arthropathy in multiple myeloma. Q J Med (1981) 0.96
Effects of intermittent pressure-induced strain on the electrophysiology of cultured human chondrocytes: evidence for the presence of stretch-activated membrane ion channels. Clin Sci (Lond) (1996) 0.96
Molecular basis of activation and regulation of the phagocyte respiratory burst. Ann Rheum Dis (1987) 0.96
Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos. Ann Rheum Dis (1973) 0.96
Gold and penicillamine: a proposed mode of action in rheumatoid arthritis, based on synovial fluid analysis. Ann Rheum Dis (1978) 0.96
Altered electrophysiological responses to mechanical stimulation and abnormal signalling through alpha5beta1 integrin in chondrocytes from osteoarthritic cartilage. Osteoarthritis Cartilage (2000) 0.95
Evidence for JNK-dependent up-regulation of proteoglycan synthesis and for activation of JNK1 following cyclical mechanical stimulation in a human chondrocyte culture model. Osteoarthritis Cartilage (2007) 0.95
Sjögren's syndrome in psoriatic arthritis, ankylosing spondylitis and Reiter's syndrome. Acta Rheumatol Scand (1971) 0.94
Differential responses of chondrocytes from normal and osteoarthritic human articular cartilage to mechanical stimulation. Biorheology (2002) 0.94
Coxsackie B infection and arthritis. Br Med J (Clin Res Ed) (1983) 0.93
Is chronic renal failure a risk factor for the development of erosive osteoarthritis? Ann Rheum Dis (1989) 0.93
Differential effects of mepacrine, chloroquine and hydroxychloroquine on superoxide anion generation, phospholipid methylation and arachidonic acid release by human blood monocytes. Biochem Pharmacol (1986) 0.92
Effect of anti-inflammatory drug therapy on clearance of 133-Xe from knee joints of patients with rheumatoid arthritis. Br Med J (1969) 0.92
Cod liver oil (n-3 fatty acids) as an non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology (Oxford) (2008) 0.92
Reversible ovulatory failure associated with the development of luteinized unruptured follicles in women with inflammatory arthritis taking non-steroidal anti-inflammatory drugs. Br J Rheumatol (1996) 0.91
The Achilles tendon reflex as an index of thyroid function. Postgrad Med J (1968) 0.91
Purine and pyrimidine nucleotide concentrations in cells with decreased hypoxanthine-guanine-phosphoribosyltransferase (HGPRT) activity. Adv Exp Med Biol (1977) 0.90
CD44 expression by leucocytes in rheumatoid arthritis and modulation by specific antibody: implications for lymphocyte adhesion to endothelial cells and synoviocytes in vitro. Scand J Immunol (1997) 0.89
Do oral corticosteroids cause osteoporosis in rheumatoid arthritis? Ann Rheum Dis (1970) 0.89
Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease. Ann Rheum Dis (1992) 0.89
An epidemiological study of fracture of the neck of femur. Health Bull (Edinb) (1986) 0.89
Total and peripheral bone mass in patients with psoriatic arthritis and rheumatoid arthritis. Clin Rheumatol (1986) 0.89
Adverse reactions in patients with rheumatic diseases. Retrospective analysis of causes of admission and out-patient attendance in a specialist centre. Ann Rheum Dis (1973) 0.88
Response of plasma membrane to applied hydrostatic pressure in chondrocytes and fibroblasts. Connect Tissue Res (1992) 0.88
CD44 is involved in selective leucocyte extravasation during inflammatory central nervous system disease. Immunology (1999) 0.87
Multicentric reticulohistiocytosis with arthritis and cardiac infiltration: regression following treatment for underlying malignancy. Ann Rheum Dis (1992) 0.87
A pilot study of the economic cost and clinical outcome of day patient vs inpatient management of active rheumatoid arthritis. Br J Rheumatol (1994) 0.86
Leg ulceration in rheumatoid arthritis. Br J Rheumatol (1994) 0.86
Erythema nodosum following typhoid vaccination. Scott Med J (1985) 0.86
Functional defects of monocyte C3b receptor-mediated phagocytosis in rheumatoid arthritis (RA): evidence for an association with the appearance of a circulating population of non-specific esterase-negative mononuclear phagocytes. Ann Rheum Dis (1983) 0.85
Rheological evidence for the existence of dissociated macromolecular complexes in rheumatoid synovial fluid. Clin Sci (1969) 0.85
Faecal flora in spondyloarthropathy. Br J Rheumatol (1997) 0.85
Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes. Ann Rheum Dis (1986) 0.84
Evidence for intrinsic cellular defects of 'complement' receptor-mediated phagocytosis in patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1984) 0.84
Wegener's granulomatosis complicated by diabetes insipidus. Ann Rheum Dis (1983) 0.84